This National Security Presidential Memorandum establishes the official United States policy for the cybersecurity of National Security Systems (NSS), directing that these systems, owned by the Department of War (DOW), Intelligence Community (IC), and Federal Civilian Executive Branch (FCEB) Agencies, must be defended to the greatest extent practicable.

The memorandum formally re-establishes the Committee on National Security Systems (CNSS) under NSC staff coordination, designates the Director of the NSA as the National Manager for NSS, and rescinds earlier governing documents.

It sets forth governance, accountability structures, mandates cybersecurity requirements equivalent to or exceeding those for other Federal systems, and details implementation steps for harmonizing policies, incident reporting, and assessing cloud security.

This Presidential Proclamation modifies prior Executive Actions (Proclamations 8031, 8335, 8337, and 9478) that established or expanded Marine National Monuments, specifically by removing certain monument-based prohibitions on commercial fishing in specified zones within the Mariana Trench Marine National Monument, the Papahānaumokuākea Marine National Monument, and surrounding Rose Atoll.

The President determined that existing comprehensive Federal laws, such as the Magnuson-Stevens Fishery Conservation and Management Act, provide sufficient authority to manage and conserve marine resources sustainably, thereby allowing for restored economic access for United States flagged commercial fishing vessels in these previously restricted areas.

This National Security Presidential Memorandum directs the comprehensive acceleration and responsible integration of Artificial Intelligence (AI) across the entire national security enterprise, including intelligence and warfighting domains.

The action is guided by four central policy pillars: Adoption of AI to enhance operational effectiveness, Adaptation by leveraging commercial and open-source technologies, Assurance that all AI is reliable and controllable, and Accountability to ensure AI use upholds U.S. civil liberties and the constitutional chain of command.

The memorandum mandates specific timelines for agency heads to update directives, establish governance frameworks, develop crucial computing infrastructure roadmaps, build AI talent reserves, and implement rigorous security testing methodologies, while also rescinding prior relevant guidance.

This Presidential Action establishes a national policy focused on maintaining U.S. leadership in Artificial Intelligence (AI) by simultaneously encouraging innovation and strengthening national security against evolving AI-related threats.

The action directs various departments, including War, Homeland Security, and the Treasury, to immediately upgrade federal system cyber defenses, prioritize the defense of National Security Systems, and establish a voluntary information-sharing arrangement with AI developers regarding "covered frontier models" to assess potential risks before public release.

Furthermore, the Attorney General is tasked with prioritizing the criminal prosecution of individuals who misuse AI to illegally access or damage computer systems.

This Presidential Action directs the Department of Health and Human Services (HHS) to review and update the United States core childhood and adolescent vaccine schedule based on a prior scientific assessment that compared U.S. recommendations to those of peer developed countries.

The policy prioritizes aligning the schedule with international best practices, ensuring continued cost-free coverage for recommended vaccines, while explicitly committing the Federal Government to protecting religious liberty and parental authority regarding these medical decisions.

This Presidential Action establishes a policy to accelerate the research, drug approval process, and access to innovative treatments, specifically psychedelic drugs like ibogaine compounds, for Americans suffering from serious mental illnesses such as major depressive disorder and substance abuse disorder, citing persistent high rates of suicide and inadequate results from standard therapies.

The order directs the FDA to prioritize review via National Priority Vouchers, mandates the establishment of access pathways via the Right to Try Act, allocates HHS funding for State partnerships, directs collaboration between HHS, FDA, and VA for data sharing, and requires the Attorney General to expedite rescheduling reviews for compounds that successfully complete Phase 3 clinical trials.

This Presidential Action addresses the perceived crisis in college sports driven by escalating financial arms races in football and basketball, coupled with inconsistent rules on athlete pay and eligibility resulting from judicial rulings and state legislation.

The order establishes new definitions for 'Improper financial activities' and 'Fraudulent NIL scheme,' and mandates executive agencies to assess compliance with new standards concerning eligibility, transfers, and revenue-sharing for federally funded institutions, effective August 1, 2026.

It strongly encourages Congress to pass legislation while simultaneously directing the Attorney General to challenge conflicting state laws and urging the relevant interstate athletic governing body to adopt specific national standards to protect women's and Olympic sports and ensure institutional financial responsibility.

This Presidential Proclamation directs adjustments to the importation of patented pharmaceuticals and associated active pharmaceutical ingredients (APIs) based on a finding that current import levels threaten national security by creating overreliance on foreign supply chains for critical medications.

The President imposes a 100% ad valorem tariff on these imports, while simultaneously offering reduced rates (20% or 0%) to companies that commit to or achieve onshoring of production and pricing agreements, and grants zero tariffs to certain specialized pharmaceutical categories.

The action also directs federal departments to pursue negotiation agreements to further secure domestic supply and requires monitoring of generic drug imports, though no immediate tariffs are placed on generics.